Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $37.1800 (2.96%) ($35.5600 - $38.0400) on Mon. May. 11, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 8.5% (three month average) | RSI | 50 | Latest Price | $37.1800(2.96%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA advances 2.9% a day on average for past five trading days. | Weekly Trend | IOVA declines -2.7% a week on average for past two weeks. | Market Behavior | Normal for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(48%) XBI(46%) ARKG(45%) IWO(42%) ARKK(41%) | Factors Impacting IOVA price | IOVA will decline at least -4.25% in a week (0% probabilities). VIXM(-24%) UUP(-16%) VXX(-13%) TBT(-5%) UNG(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -4.25% (StdDev 8.5%) | Hourly BBV | 0 () | Intraday Trend | 3.2% | | | |
|
5 Day Moving Average | $34.47(7.86%) | 10 Day Moving Average | $33.66(10.46%) | 20 Day Moving Average | $34.85(6.69%) | To recent high | -4.3% | To recent low | 90.3% | Market Cap | $5.444b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |